Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 62.00 | 71.25 | 0.8702 | 0.8005 | |
SK-BR-3 | Palbociclib | 0.031623 | uM | 5 | 156.25 | 28.48 | 82.00 | 71.25 | 1.1509 | 1.2241 |
SK-BR-3 | Taxol | 1 | uM | 5 | 156.25 | 28.48 | 89.00 | 71.25 | 1.2491 | 1.3662 |
SK-BR-3 | Palbociclib | 3.1623 | uM | 5 | 156.25 | 28.48 | 64.00 | 71.25 | 0.8983 | 0.8442 |
SK-BR-3 | Omipalisib | 0.0033113 | uM | 5 | 156.25 | 28.48 | 81.00 | 71.25 | 1.1368 | 1.2036 |
SK-BR-3 | Methotrexate | 0.1 | uM | 5 | 156.25 | 28.48 | 85.00 | 71.25 | 1.1930 | 1.2854 |
SK-BR-3 | Omipalisib | 10 | uM | 5 | 156.25 | 28.48 | 75.00 | 71.25 | 1.0526 | 1.0791 |
SK-BR-3 | Methotrexate | 1 | uM | 5 | 156.25 | 28.48 | 82.00 | 71.25 | 1.1509 | 1.2241 |
SK-BR-3 | Methotrexate | 0.0033113 | uM | 5 | 156.25 | 28.48 | 55.00 | 71.25 | 0.7719 | 0.6446 |
SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 46.00 | 71.25 | 0.6456 | 0.4368 | |
SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 56.00 | 71.25 | 0.7860 | 0.6671 | |
SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 68.00 | 71.25 | 0.9544 | 0.9307 | |
SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 94.00 | 71.25 | 1.3193 | 1.4660 | |
SK-BR-3 | Taxol | 0.01 | uM | 5 | 156.25 | 28.48 | 79.00 | 71.25 | 1.1088 | 1.1623 |
SK-BR-3 | Taxol | 0.1 | uM | 5 | 156.25 | 28.48 | 99.00 | 71.25 | 1.3895 | 1.5645 |
SK-BR-3 | Methotrexate | 0.31623 | uM | 5 | 156.25 | 28.48 | 102.00 | 71.25 | 1.4316 | 1.6230 |
SK-BR-3 | Taxol | 0.00016596 | uM | 5 | 156.25 | 28.48 | 99.00 | 71.25 | 1.3895 | 1.5645 |
SK-BR-3 | Palbociclib | 19.9526 | uM | 5 | 156.25 | 28.48 | 77.00 | 71.25 | 1.0807 | 1.1208 |
SK-BR-3 | Omipalisib | 0.1 | uM | 5 | 156.25 | 28.48 | 54.00 | 71.25 | 0.7579 | 0.6219 |
SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 80.00 | 71.25 | 1.1228 | 1.1830 | |
SK-BR-3 | Palbociclib | 1 | uM | 5 | 156.25 | 28.48 | 69.00 | 71.25 | 0.9684 | 0.9521 |
SK-BR-3 | Omipalisib | 3.1623 | uM | 5 | 156.25 | 28.48 | 59.00 | 71.25 | 0.8281 | 0.7342 |
SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 40.00 | 71.25 | 0.5614 | 0.2928 | |
SK-BR-3 | Omipalisib | 1 | uM | 5 | 156.25 | 28.48 | 79.00 | 71.25 | 1.1088 | 1.1623 |
SK-BR-3 | Methotrexate | 0.0016596 | uM | 5 | 156.25 | 28.48 | 58.00 | 71.25 | 0.8140 | 0.7119 |